ASCOT: a tale of two treatment regimensBMJ 2005; 331 doi: http://dx.doi.org/10.1136/bmj.331.7523.1022-a (Published 27 October 2005) Cite this as: BMJ 2005;331:1022
Is ASCOT-BPLA being hyped-up?
- Peter D Burrill, assistant director of public health ([email protected])
- Prescribing and Clinical Effectiveness, Chesterfield Primary Care Trust, Chesterfield S41 7PF
EDITOR—McDougall et al discuss whether the small absolute differences in secondary outcomes seen in the ASCOT-BPLA study were attributable to the blood pressure differences achieved.1 They use the accompanying paper to argue that this was in fact not so.2
However, the editorial that accompanies the ASCOT-BPLA study severely criticises this post-hoc analysis and considers that the 2.7 mm Hg …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial